医学
药代动力学
药理学
传统医学
药品
重症监护医学
梅德林
临床试验
疾病
动作(物理)
作者
Madhavi Latha Samala,Anu Pravallika Janipalli,Gowri Gollu,Nalini Mathala
出处
期刊:Wiley eBooks
[Wiley]
日期:2026-09-25
卷期号:: 150-163
标识
DOI:10.1002/9781394402557.ch12
摘要
Herbal medicines are globally accepted because of their efficiency in cardiovascular health management, offering antioxidant, anti-inflammatory, antihypertensive, and lipid-lowering effects. However, their complex chemical compositions exhibit significant toxicological and pharmacokinetic challenges, which should be critically evaluated to ensure safe and effective use. Phytochemicals, contaminants, and adulterants of herbal medicines elicit herb–drug interactions and toxic effects, particularly in cardiovascular patients, as they receive multiple drug regimens on a daily basis. Better therapeutic outcomes and safety profiles can be predicted by thorough understanding of the absorption, distribution, metabolism, and excretion (ADME) of herbal constituents. Integration of in vitro , in vivo , and in silico toxicology data ensures efficient use of phytomedicines with reduced risks. This chapter explores the importance of integrating toxicological and pharmacokinetic assessments into the development and clinical application of cardiovascular phytomedicines.
科研通智能强力驱动
Strongly Powered by AbleSci AI